Zurück zu Projekte

14666.1 PFLS-LS

Immunotherapy against Alzheimer's disease: encapsulated cell devices as a platform for passive immunization

Zusammenfassung

Immunotherapy against Alzheimer's disease: encapsulated cell devices as a platform for passive immunization

Weitere Texte

Abstract

The project will develop an innovative bioactive implant for passive immunization against toxic protein entities involved in|neurodegenerative brain disorders. In particular, we will focus on immunotherapy against the amyloid ! peptide, which|abnormally accumulates in the brain of Alzheimer¿s disease patients and is considered a primary actor in the disease process.|Early intervention is key to the success of neuroprotective treatments for Alzheimer¿s disease. Therefore, our aim is to make|preventive immunization against the amyloid ! peptide affordable to patients using self-sustaining and retrievable cellular|implants.

Beteiligte

Bernd Bohrmann

Wirtschaftspartner

bernd.bohrmann@roche.com

F. Hoffmann-La Roche AG CHE-105.815.381 Bernd Bohrmann Grenzacherstrasse 124 4070 Basel BS CH

Bernard Schneider

Kontaktperson

bernard.schneider@epfl.ch

EPFL IC IIF LABOS Bernard Schneider Station 9, Bâtiment AI 2241 1015 Lausanne VD CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2012-11-30
Enddatum
2015-05-31
Bewilligte Gesamtkosten
CHF 460727.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Industrielle Produktivität und Technologie

Forschungsdisziplinen

  • T115 Medical technology 100.0%